OTCMKTS:PXSLY

Pharmaxis (PXSLY) Stock Price, News & Analysis

Pharmaxis logo
$0.88 0.00 (0.00%)
As of 06/8/2021

About Pharmaxis Stock (OTCMKTS:PXSLY)

Key Stats

Today's Range
$0.88
▼
$0.88
50-Day Range
$0.88
▼
$0.88
52-Week Range
$0.62
▼
$1.47
Volume
N/A
Average Volume
1,000 shs
Market Capitalization
$26.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharmaxis is an Australian biopharmaceutical company that develops treatments and diagnostic products for respiratory conditions and other diseases. Its commercial products include Bronchitol, an inhaled mannitol treatment for cystic fibrosis, and Aridol, a mannitol-based test used to assess airway responsiveness.

The company also develops medicines for conditions including fibrosis and blood cancers. Its research has included inhibitors of lysyl oxidase enzymes, which are involved in tissue scarring and disease processes.

Based in Australia, Pharmaxis has pursued international markets for its respiratory products and works on drug development programs with potential applications beyond respiratory disease.

AI Generated. May Contain Errors.

Receive PXSLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharmaxis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PXSLY Stock News Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
Pharmaxis Ltd March Quarter Shareholder Update
See More Headlines

PXSLY Stock Analysis - Frequently Asked Questions

Pharmaxis' stock was trading at $0.88 on January 1st, 2026. Since then, PXSLY stock has increased by 0.0% and is now trading at $0.88.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:PXSLY
CIK
1301357
Fax
N/A
Employees
69
Year Founded
1998

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
2.82
Current Ratio
3.31
Quick Ratio
2.92

Sales & Book Value

Annual Sales
$8.75 million
Price / Sales
3.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
22.00

Miscellaneous

Outstanding Shares
30,150,000
Free Float
N/A
Market Cap
$26.53 million
Optionable
Not Optionable
Beta
1.22

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:PXSLY) was last updated on 6/8/2021 by MarketBeat.com Staff.
From Our Partners